Biochemical Reagent
-
BA2983 BatabulinSummary: Batabulin (T138067) is an antitumor agent that covalently and selectively binds to a subset of beta-microtubule protein isoforms, thereby disrupting microtubule polymerization. - BA2984 STAT3-IN-13Summary: STAT3-IN-13 is a potent inhibitor.
- BA2985 Thalidomide-O-PEG2-propargylSummary: Thalidomide-O-PEG2-propargyl (E3ligaseLigand-LinkerConjugates32) is a synthesized E3 ligase ligand-linker coupler comprising a Thalidomide-based ligand and a 2-unit PEG linker for technical applications.
- BA2986 CDK9-IN-7Summary: CDK9-IN-7 is a highly potent and selective, orally active inhibitor.
- BA2987 KS106Summary: KS106 is a potent inhibitor.
- BA2988 BTM-3566Summary: BTM-3566 is an activator.
- BA2989 IfabotuzumabSummary: Ifabotuzumab (KB004) is a targeted IgG1κ antibody (K=610pM).
- BA2990 TL4-12Summary: TL4-12 is a selective inhibitor that downregulates IKZF1 and BCL-6 and inhibits MM cell proliferation (IC=37nM) and induces apoptosis.
- BA2991 PCAF-IN-2Summary: PCAF-IN-2 is a potent inhibitor.
- BA2992 STAT3-IN-12Summary: STAT3-IN-12 is a potent signaling inhibitor that inhibits the induced activation of the JAK/STAT3 signaling pathway.